Skip to main content
. 2014 Nov 24;9(11):e113622. doi: 10.1371/journal.pone.0113622

Table 2. Summary of EC50s from experiments measuring IP1 accumulation and ERK1/2 phosphorylation.

Mutants EC50 (IP1-Elisa) EC50 (ERK1/2 activity)
Without L-Phe With L-Phe With L-Phe Without L-Phe With L-Phe
WT 2.9±0.3 2.0±0.1* 3.0±0.1 1.9±0.1*
L173F 1.2±0.1# 1.0±0.1 2.7±0.1# 1.6±0.1*
P221L 1.1±0.1# 0.9±0.1 2.2±0.3# 1.7±0.2
L173P 10.7±1.0# 9.0±0.9 14.9±1.0# 13.5±0.8
P221Q 6.1±0.3# 4.5±0.4* 11.9±0.3# 9.5±0.4*

HEK293 cells were transiently transfected with the WT CaSR or disease-associated CaSR mutants. Cells were then treated with various levels of [Ca2+]o. The EC50s of [Ca2+]o-IP1 responses and the -[Ca2+]o-ERK1/2 phosphorylation activity responses were obtained from curve fitting using the Hill equation as mentioned in Method. # indicates significance with respect to wild type CaSR, p<0.05 (ANOVA, Dunnett test); * indicates significance with respect to the corresponding mutants in the absence of L-Phe, p<0.05 (two-way ANOVA).